Report Detail

Other Global Overactive Bladder Treatment Market Research Report 2019

  • RnM2922233
  • |
  • 11 February, 2019
  • |
  • Global
  • |
  • 99 Pages
  • |
  • QYResearch
  • |
  • Other

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.

Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.

The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.

The global Overactive Bladder Treatment market is valued at 4710 million US$ in 2018 is expected to reach 7230 million US$ by the end of 2025, growing at a CAGR of 5.5% during 2019-2025.
This report focuses on Overactive Bladder Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Overactive Bladder Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Anticholinergics
Mirabegron
Botox

Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder


Table of Contents

    Executive Summary

      1 Overactive Bladder Treatment Market Overview

      • 1.1 Product Overview and Scope of Overactive Bladder Treatment
      • 1.2 Overactive Bladder Treatment Segment by Type
        • 1.2.1 Global Overactive Bladder Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Anticholinergics
        • 1.2.3 Mirabegron
        • 1.2.4 Botox
      • 1.3 Overactive Bladder Treatment Segment by Application
        • 1.3.1 Overactive Bladder Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Idiopathic Overactive Bladder
        • 1.3.3 Neurogenic Overactive Bladder
      • 1.3 Global Overactive Bladder Treatment Market by Region
        • 1.3.1 Global Overactive Bladder Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Overactive Bladder Treatment Market Size
        • 1.4.1 Global Overactive Bladder Treatment Revenue (2014-2025)
        • 1.4.2 Global Overactive Bladder Treatment Production (2014-2025)

      2 Global Overactive Bladder Treatment Market Competition by Manufacturers

      • 2.1 Global Overactive Bladder Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Overactive Bladder Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Overactive Bladder Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Overactive Bladder Treatment Production Sites, Area Served, Product Types
      • 2.5 Overactive Bladder Treatment Market Competitive Situation and Trends
        • 2.5.1 Overactive Bladder Treatment Market Concentration Rate
        • 2.5.2 Overactive Bladder Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Overactive Bladder Treatment Production Market Share by Regions

      • 3.1 Global Overactive Bladder Treatment Production Market Share by Regions
      • 3.2 Global Overactive Bladder Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Overactive Bladder Treatment Production
        • 3.4.1 North America Overactive Bladder Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Overactive Bladder Treatment Production
        • 3.5.1 Europe Overactive Bladder Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Overactive Bladder Treatment Production (2014-2019)
        • 3.6.1 China Overactive Bladder Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Overactive Bladder Treatment Production (2014-2019)
        • 3.7.1 Japan Overactive Bladder Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Overactive Bladder Treatment Consumption by Regions

      • 4.1 Global Overactive Bladder Treatment Consumption by Regions
      • 4.2 North America Overactive Bladder Treatment Consumption (2014-2019)
      • 4.3 Europe Overactive Bladder Treatment Consumption (2014-2019)
      • 4.4 China Overactive Bladder Treatment Consumption (2014-2019)
      • 4.5 Japan Overactive Bladder Treatment Consumption (2014-2019)

      5 Global Overactive Bladder Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Overactive Bladder Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Overactive Bladder Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Overactive Bladder Treatment Price by Type (2014-2019)
      • 5.4 Global Overactive Bladder Treatment Production Growth by Type (2014-2019)

      6 Global Overactive Bladder Treatment Market Analysis by Applications

      • 6.1 Global Overactive Bladder Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Overactive Bladder Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Overactive Bladder Treatment Business

      • 7.1 Astellas Pharma
        • 7.1.1 Astellas Pharma Overactive Bladder Treatment Production Sites and Area Served
        • 7.1.2 Overactive Bladder Treatment Product Introduction, Application and Specification
        • 7.1.3 Astellas Pharma Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Allergan
        • 7.2.1 Allergan Overactive Bladder Treatment Production Sites and Area Served
        • 7.2.2 Overactive Bladder Treatment Product Introduction, Application and Specification
        • 7.2.3 Allergan Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Pfizer
        • 7.3.1 Pfizer Overactive Bladder Treatment Production Sites and Area Served
        • 7.3.2 Overactive Bladder Treatment Product Introduction, Application and Specification
        • 7.3.3 Pfizer Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Teva (Activas)
        • 7.4.1 Teva (Activas) Overactive Bladder Treatment Production Sites and Area Served
        • 7.4.2 Overactive Bladder Treatment Product Introduction, Application and Specification
        • 7.4.3 Teva (Activas) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Johnson & Johnson
        • 7.5.1 Johnson & Johnson Overactive Bladder Treatment Production Sites and Area Served
        • 7.5.2 Overactive Bladder Treatment Product Introduction, Application and Specification
        • 7.5.3 Johnson & Johnson Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served

      8 Overactive Bladder Treatment Manufacturing Cost Analysis

      • 8.1 Overactive Bladder Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Overactive Bladder Treatment
      • 8.4 Overactive Bladder Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Overactive Bladder Treatment Distributors List
      • 9.3 Overactive Bladder Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Overactive Bladder Treatment Market Forecast

      • 11.1 Global Overactive Bladder Treatment Production, Revenue Forecast
        • 11.1.1 Global Overactive Bladder Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Overactive Bladder Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Overactive Bladder Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Overactive Bladder Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Overactive Bladder Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Overactive Bladder Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Overactive Bladder Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Overactive Bladder Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Overactive Bladder Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Overactive Bladder Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Overactive Bladder Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Overactive Bladder Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Overactive Bladder Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Overactive Bladder Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Overactive Bladder Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Overactive Bladder Treatment . Industry analysis & Market Report on Overactive Bladder Treatment is a syndicated market report, published as Global Overactive Bladder Treatment Market Research Report 2019. It is complete Research Study and Industry Analysis of Overactive Bladder Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,288.10
        3,432.15
        4,576.20
        2,708.60
        4,062.90
        5,417.20
        456,692.00
        685,038.00
        913,384.00
        242,382.00
        363,573.00
        484,764.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report